Company intelligence / Profile preview

Zodiac Produtos Farmacêuticos

Pindamonhangaba, São Paulo, Brazil

Ownership: Private
Employees: ~600
Development stage: Other

Overview

Zodiac Produtos Farmacêuticos is a leading Brazilian specialty pharmaceutical company and a subsidiary of the Adium Pharma group. The company focuses on the commercialization, manufacturing, and distribution of high-complexity therapies in oncology, hematology, urology, and pain management. It is a major strategic partner for global biotechnology companies seeking to bring innovative treatments to the Latin American market, managing a portfolio of licensed blockbuster drugs and high-quality generic products.

Therapeutic areas: OncologyNeurologyWomen's Health
Modalities: Antibody-drug conjugateSmall moleculePeptidesMonoclonal antibodyHormone
Industry: Biotech

Partnerships

PfizerDeciphera PharmaceuticalsTakedaAstellasJanssenPierre FabreRecordatiAVEO Oncology

Beyond the preview

Go deeper on Zodiac Produtos Farmacêuticos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zodiac Produtos Farmacêuticos.

Explore the full profile